Infocus Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-06-2024
- Paid Up Capital ₹ 0.10 M
as on 30-06-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2021)
- Ebitda
- Net Worth
- Total Assets 30.98%
(FY 2021)
About Infocus Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Akash Mahendra, Aditya Sadaria, and Sobhnaben Sadariya serve as directors at the Company.
- CIN/LLPIN
U33112GJ2018PTC101679
- Company No.
101679
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Infocus Remedies Private Limited offer?
Infocus Remedies Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Antianginal Drugs, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Diclofenac, Blood Pressure Medicine, Digestive System Drugs & Medicines, Antacid Drugs, Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing.
Who are the key members and board of directors at Infocus Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akash Mahendra  | Director | 06-Apr-2018 | Current |
| Aditya Sadaria | Director | 06-Apr-2018 | Current |
| Sobhnaben Sadariya | Director | 06-Apr-2018 | Current |
Financial Performance of Infocus Remedies.
Infocus Remedies Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Infocus Remedies?
Unlock access to Infocus Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rethink Pharma Private LimitedActive 1 year 5 monthsAkash Mahendra and Aditya Sadaria are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Infocus Remedies?
Unlock and access historical data on people associated with Infocus Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Infocus Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Infocus Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
